Literature DB >> 11156592

Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase.

A D Qi1, C Kennedy, T K Harden, R A Nicholas.   

Abstract

1. The human P2Y(11) (hP2Y(11)) receptor was stably expressed in two cell lines, 1321N1 human astrocytoma cells (1321N1-hP2Y(11)) and Chinese hamster ovary cells (CHO-hP2Y(11)), and its coupling to phospholipase C and adenylyl cyclase was assessed. 2. In 1321N1-hP2Y(11) cells, ATP promoted inositol phosphate (IP) accumulation with low microM potency (EC(50)=8.5+/-0.1 microM), whereas it was 15 fold less potent (130+/-10 microM) in evoking cyclic AMP production. 3. In CHO-hP2Y(11) cells, ATP promoted IP accumulation with slightly higher potency (EC(50)=3.6+/-1.3 microM) than in 1321N1-hP2Y(11) cells, but it was still 15 fold less potent in promoting cyclic AMP accumulation (EC(50)=62.4+/-15.6 microM) than for IP accumulation. Comparable differences in potencies for promoting the two second messenger responses were observed with other adenosine nucleotide analogues. 4. In 1321N1-hP2Y(11) and CHO-hP2Y(11) cells, down regulation of PKC by chronic treatment with phorbol ester decreased ATP-promoted cyclic AMP accumulation by 60--80% (P<0.001) with no change in its potency. Likewise, chelation of intracellular Ca(2+) decreased ATP-promoted cyclic AMP accumulation by approximately 45% in 1321N1-hP2Y(11) cells, whereas chelation had no effect on either the efficacy or potency of ATP in CHO-hP2Y(11) cells. 5. We conclude that coupling of hP2Y(11) receptors to adenylyl cyclase in these cell lines is much weaker than coupling to phospholipase C, and that activation of PKC and intracellular Ca(2+) mobilization as consequences of inositol lipid hydrolysis potentiates the capacity of ATP to increase cyclic AMP accumulation in both 1321N1-hP2Y(11) and CHO-hP2Y(11) cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156592      PMCID: PMC1572546          DOI: 10.1038/sj.bjp.0703788

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

Review 1.  Catalytic mechanism and regulation of mammalian adenylyl cyclases.

Authors:  W J Tang; J H Hurley
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436

2.  Potentiation of receptor-mediated cAMP production: role in the cross-talk between vasopressin V1a and V2 receptor transduction pathways.

Authors:  C Klingler; N Ancellin; M B Barrault; A Morel; B Corman
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.

Authors:  C Léon; B Hechler; C Vial; C Leray; J P Cazenave; C Gachet
Journal:  FEBS Lett       Date:  1997-02-10       Impact factor: 4.124

4.  ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.

Authors:  C Kennedy; A D Qi; C L Herold; T K Harden; R A Nicholas
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

5.  Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction.

Authors:  S Houssami; D M Findlay; C L Brady; D E Myers; T J Martin; P M Sexton
Journal:  Endocrinology       Date:  1994-07       Impact factor: 4.736

6.  A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates.

Authors:  J L Boyer; S M Delaney; D Villanueva; T K Harden
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

7.  Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.

Authors:  E R Lazarowski; W C Watt; M J Stutts; R C Boucher; T K Harden
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Authors:  A B Abou-Samra; H Jüppner; T Force; M W Freeman; X F Kong; E Schipani; P Urena; J Richards; J V Bonventre; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

9.  Psychomotor-stimulant effects of 3-isobutyl-1-methylxanthine: comparison with caffeine and 7-(2-chloroethyl) theophylline.

Authors:  V L Coffin; R D Spealman
Journal:  Eur J Pharmacol       Date:  1989-10-24       Impact factor: 4.432

10.  Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.

Authors:  D Ukena; K A Jacobson; W L Padgett; C Ayala; M T Shamim; K L Kirk; R O Olsson; J W Daly
Journal:  FEBS Lett       Date:  1986-12-01       Impact factor: 4.124

View more
  26 in total

Review 1.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

2.  Charged residues in the C-terminus of the P2Y1 receptor constitute a basolateral-sorting signal.

Authors:  Samuel C Wolff; Ai-Dong Qi; T Kendall Harden; Robert A Nicholas
Journal:  J Cell Sci       Date:  2010-07-15       Impact factor: 5.285

Review 3.  P2 receptors: intracellular signaling.

Authors:  Laurie Erb; Zhongji Liao; Cheikh I Seye; Gary A Weisman
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Reactome pathway analysis to enrich biological discovery in proteomics data sets.

Authors:  Robin Haw; Henning Hermjakob; Peter D'Eustachio; Lincoln Stein
Journal:  Proteomics       Date:  2011-09       Impact factor: 3.984

6.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

7.  Apical targeting of the P2Y(4) receptor is directed by hydrophobic and basic residues in the cytoplasmic tail.

Authors:  D Ross DuBose; Samuel C Wolff; Ai-Dong Qi; Izabela Naruszewicz; Robert A Nicholas
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-10       Impact factor: 4.249

Review 8.  A critical look at the function of the P2Y11 receptor.

Authors:  Karin Dreisig; Birgitte Rahbek Kornum
Journal:  Purinergic Signal       Date:  2016-05-31       Impact factor: 3.765

9.  Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors.

Authors:  Liaman K Mamedova; Bhalchandra V Joshi; Zhan-Guo Gao; Ivar von Kügelgen; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-05-01       Impact factor: 5.858

10.  A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.

Authors:  Matthew O Barrett; Juliana I Sesma; Christopher B Ball; P Suresh Jayasekara; Kenneth A Jacobson; Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2013-04-16       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.